BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
0.6000
-0.0060 (-1.00%)
Apr 1, 2025, 10:15 AM EDT - Market open

Company Description

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms.

It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines.

The company’s product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy.

The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system.

BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BioSig Technologies, Inc.
BioSig Technologies logo
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 4
CEO Anthony Amato

Contact Details

Address:
55 Greens Farms Road, 1st Floor
Westport, Connecticut 06880
United States
Phone 203 409 5444
Website biosig.com

Stock Details

Ticker Symbol BSGM
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001530766
CUSIP Number 09073N201
ISIN Number US09073N3008
Employer ID 26-4333375
SIC Code 3845

Key Executives

Name Position
Anthony Amato Chief Executive Officer and Chairman
Ferdinand Groenewald Interim Chief Financial Officer and Principal Accounting Officer
Dr. Budimir S. Drakulic Ph.D. Chief Scientist
Lora Mikolaitis Chief Administrative Officer

Latest SEC Filings

Date Type Title
Mar 31, 2025 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 26, 2025 D Notice of Exempt Offering of Securities
Mar 25, 2025 8-K Current Report
Mar 6, 2025 8-K Current Report
Mar 5, 2025 8-K Current Report
Mar 3, 2025 8-K Current Report
Jan 13, 2025 S-8 Securities to be offered to employees in employee benefit plans
Dec 31, 2024 8-K Current Report
Dec 18, 2024 8-K Current Report
Dec 18, 2024 424B5 Filing